Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1941 2
1949 1
1951 1
1954 1
1955 1
1957 3
1960 1
1961 3
1962 1
1963 2
1965 5
1966 1
1967 3
1968 5
1969 9
1970 2
1971 4
1972 7
1973 5
1974 6
1975 5
1976 6
1977 5
1978 15
1979 12
1980 7
1981 13
1982 16
1983 16
1984 16
1985 11
1986 23
1987 27
1988 23
1989 31
1990 42
1991 36
1992 35
1993 46
1994 51
1995 55
1996 61
1997 74
1998 86
1999 95
2000 128
2001 153
2002 175
2003 181
2004 232
2005 319
2006 366
2007 440
2008 451
2009 505
2010 606
2011 663
2012 751
2013 707
2014 863
2015 908
2016 882
2017 862
2018 876
2019 928
2020 1023
2021 1043
2022 907
2023 816
2024 411

Text availability

Article attribute

Article type

Publication date

Search Results

14,294 results

Results by year

Filters applied: . Clear all
Page 1
Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer.
Wu YL, Dziadziuszko R, Ahn JS, Barlesi F, Nishio M, Lee DH, Lee JS, Zhong W, Horinouchi H, Mao W, Hochmair M, de Marinis F, Migliorino MR, Bondarenko I, Lu S, Wang Q, Ochi Lohmann T, Xu T, Cardona A, Ruf T, Noe J, Solomon BJ; ALINA Investigators. Wu YL, et al. Among authors: lee js. N Engl J Med. 2024 Apr 11;390(14):1265-1276. doi: 10.1056/NEJMoa2310532. N Engl J Med. 2024. PMID: 38598794 Clinical Trial.
Preclinical and dose-ranging assessment of hESC-derived dopaminergic progenitors for a clinical trial on Parkinson's disease.
Park S, Park CW, Eom JH, Jo MY, Hur HJ, Choi SK, Lee JS, Nam ST, Jo KS, Oh YW, Lee J, Kim S, Kim DH, Park CY, Kim SJ, Lee HY, Cho MS, Kim DS, Kim DW. Park S, et al. Among authors: lee js. Cell Stem Cell. 2024 Jan 4;31(1):25-38.e8. doi: 10.1016/j.stem.2023.11.009. Epub 2023 Dec 11. Cell Stem Cell. 2024. PMID: 38086390 Free article.
SKYSCRAPER-02: Tiragolumab in Combination With Atezolizumab Plus Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer.
Rudin CM, Liu SV, Soo RA, Lu S, Hong MH, Lee JS, Bryl M, Dumoulin DW, Rittmeyer A, Chiu CH, Ozyilkan O, Johnson M, Navarro A, Novello S, Ozawa Y, Tam SH, Patil NS, Wen X, Huang M, Hoang T, Meng R, Reck M. Rudin CM, et al. Among authors: lee js. J Clin Oncol. 2024 Jan 20;42(3):324-335. doi: 10.1200/JCO.23.01363. Epub 2023 Nov 17. J Clin Oncol. 2024. PMID: 37976444 Free PMC article. Clinical Trial.
Gridlock in hospital medicine.
Readlynn JK, Zagursky J, Burke RE, Lee JSG, Olson APJ. Readlynn JK, et al. Among authors: lee jsg. J Hosp Med. 2023 Dec 12. doi: 10.1002/jhm.13259. Online ahead of print. J Hosp Med. 2023. PMID: 38085675 No abstract available.
Aldosterone and aldosterone synthase inhibitors in cardiorenal disease.
Verma S, Pandey A, Pandey AK, Butler J, Lee JS, Teoh H, Mazer CD, Kosiborod MN, Cosentino F, Anker SD, Connelly KA, Bhatt DL. Verma S, et al. Among authors: lee js. Am J Physiol Heart Circ Physiol. 2024 Mar 1;326(3):H670-H688. doi: 10.1152/ajpheart.00419.2023. Epub 2023 Dec 22. Am J Physiol Heart Circ Physiol. 2024. PMID: 38133623 Review.
14,294 results
You have reached the last available page of results. Please see the User Guide for more information.